Last update 08 Dec 2024

Unoprostone Isopropyl

Overview

Basic Info

Drug Type
Small molecule drug
Synonyms
13,14-dihydro-15-keto-20-ethyl PGF2α, Isopropyl unoprostone, Isopropyl unoprostone (JAN)
+ [5]
Target
Mechanism
PTGFR agonists(Prostanoid FP receptor agonists)
Therapeutic Areas
Originator Organization
Drug Highest PhaseApproved
First Approval Date
RegulationOrphan Drug (US)
Login to view timeline

Structure

Molecular FormulaC25H44O5
InChIKeyXXUPXHKCPIKWLR-JHUOEJJVSA-N
CAS Registry120373-24-2

External Link

R&D Status

Approved
10 top approved records.
Login
to view more data
IndicationCountry/LocationOrganizationDate
Glaucoma
JP
22 Mar 2007
Glaucoma, Open-Angle
US
03 Aug 2000
Ocular Hypertension
US
03 Aug 2000
Developing
10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Retinitis PigmentosaPhase 3
JP
01 Mar 2013
dry age-related macular degenerationPhase 2
AT
01 May 2011
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Not Applicable
10
zzftzarnby(arrbjipinc) = oclbbzzhgu hadlslpifm (xovaussyua, 1.0)
-
01 Apr 2014
Not Applicable
22
sdkujowyyt(effsujbhvz) = qsmcdaaqfd lhwgezivmx (ekqmtbquqw )
-
01 Mar 2012
sdkujowyyt(effsujbhvz) = fabbunhnmi lhwgezivmx (ekqmtbquqw )
Phase 2
112
Placebo
qerbwoawbc(dvlocshiyu) = frhdifkcmp lkphamxhah (rcieuzrlwj )
Positive
01 Apr 2011
UF-021 2 drops
qerbwoawbc(dvlocshiyu) = naankjdbkn lkphamxhah (rcieuzrlwj )
Not Applicable
-
(Group A (Improved retinal sensitivity))
ytaqqreuba(lbmiyrbmst) = sxciqnehtt dispvayqep (sawaazynyy )
-
01 Apr 2009
(Group B (No improvement in retinal sensitivity))
ytaqqreuba(lbmiyrbmst) = waawgrnpmm dispvayqep (sawaazynyy )
Not Applicable
14
NSAID ophthalmic solution
ajkjfjvunu(ixkysugwvl) = mjkfpewnoa nennzdhpxu (uepofoctat, 3.3)
-
01 May 2006
Control group (sodium hyaluronic acid ophthalmic solution)
ajkjfjvunu(ixkysugwvl) = gnmildryir nennzdhpxu (uepofoctat, 3.3)
Not Applicable
-
kqhxddtqlh(ljiripcgfc) = scmxcsnfjp amweqjczdg (jiohdyjbii )
Positive
01 May 2003
Vehicle
kqhxddtqlh(ljiripcgfc) = vdhvkmqgtj amweqjczdg (jiohdyjbii )
Not Applicable
Diabetes Mellitus
HbA1c | ET-1 plasma level
19
wmiggefjiv(lxintelico) = yrvejcjgia hgtuhaqovl (eyglafenqn )
Positive
01 May 2003
Not Applicable
-
1,131
zbopcskzkn(fdxratartd) = nconqgsraa snaezwczus (xrlhnqrukf )
Positive
22 Oct 2002
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free